Adial Pharmaceuticals (ADIL) Acquisitions (2021)
Adial Pharmaceuticals (ADIL) posted Acquisitions of -$30589.0 for Q1 2021.
Adial Pharmaceuticals (ADIL) Acquisitions (2021) Analysis & Trends
Adial Pharmaceuticals has reported Acquisitions for 1 years, with the latest figure at -$30589.0 in Q1 2021.
- Quarterly Acquisitions changed N/A year-over-year to -$30589.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was -$30589.0 (changed N/A YoY) and the FY2021 annual result came in at -$30589.0, changed N/A from the prior year.
- Acquisitions steadied at -$30589.0 in Q1 2021 per ADIL's latest filing.
- Over five years, Acquisitions peaked at -$30589.0 in Q1 2021 and troughed at -$30589.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | - |
| 10 | Adial Pharmaceuticals | 27.37 Mn | 27.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -30,589.00 |